Table 2.
Overview of ligands for positron emission tomography (PET) imaging of dopamine D2/3 receptors.
Ligand (Alpha- Betic Order) | Rodent, Pig or Cat Study |
Monkey or Baboon Study |
Human Study |
Comments |
---|---|---|---|---|
[18F]Benperidol | [287,288] | |||
[18F]DMFP | [289,290,291] | [292,293] | Longer half-life than [11C]raclopride |
|
N-Ethyl-[11C]- eticlopride |
[294] | |||
[11C]Fallypride | [295] | [296] | ||
[18F]Fallypride | [291,297,298,299] | [297,300,301,302,303,304] | [305,306,307,308,309,310,311] | High-affinity, visualizes also extrastriatal D2R, numerous studies * |
[18F]FCP | [312] | |||
[18F]FEBF | [313] | |||
[18F]FESP | [314,315] | [314,315,316] | [314,317] | |
[11C]FLB457 | [318] | [319,320] | [296,321,322,323,324,325,326,327,328] | High-affinity, visualizes also extrastriatal D2R, numerous studies * |
[11C]FLB524 | [329] | [329] | ||
5-[18F]FPE | [330] | |||
[18F]FPSP | [315,331] | [315,331] | [331] | |
[18F]Haloperidol | [332,333] | [334] | Binds also to sigmaR | |
[18F]MABN | [335] | [336] | ||
[18F]MBP | [335] | [312,336] | Binds also to rho1 | |
Methyl-[11C]- eticlopride |
[294] | |||
[11C]MNPA | [337] | [338,339] | [340] | Agonist ligand |
[11C]Nemonapride | [341,342,343] | Binds also to sigmaR | ||
[11C]NMSP | [341,344,345] | [346,347,348,349] | ||
[18F]NMSP | [350] | [336,350] | [351] | |
[11C]NPA | [352,353] | [352,354,355] | [356,357,358] | Agonist ligand |
[11C]PPHT | [359,360] | [359] | Agonist ligand | |
[11C]Raclopride | [361,362] | [363,364,365,366,367] | [368,369,370,371,372,373,374,375,376,377,378,379] | Moderate affinity, visualizes mainly striatal D2R, numerous studies * |
[18F]Spiperone | [287] | |||
[11C]SV-III-130 | [380] | Partial agonist ligand | ||
[11C]ZYY339 | [359,360] | [359] | Agonist ligand |
* Only a small selection of the available publications is cited for this radioligand. DMFP = Desmethoxyfallypride, FCP = Fluoroclebopride, FEBF = Fluorethyl-2,3-dihydrobenzofuran, FESP = Fluoroethyl- spiperone, FPE = Fluoropropyl-epidepride, FPSP = Fluoropropyl-spiperone, MABN = 2,3-dimethoxy-N-[9-(4-fluorobenzyl) -9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide, MBP = 2,3-dimethoxy-N-[1-(4-fluorobenzyl)piperidin4yl]benzamide, MNPA = Methoxy-N-n-propylnorapomorphine, NMSP = N-methyl-spiperone, NPA = N-n-propylnorapomorphine, PPHT = (+/−)-2-(N- phenethyl-N-propyl)amino-5-hydroxytetralin. Other compounds are numbere by the producing institutions or pharmaceutical companies.